G01N 2800/306
Chronic fatigue syndrome
G01N2800/306 (Chronic fatigue syndrome) appears on 13 US grants and 25 published applications in this corpus.
Search patents in G01N- Granted patents
- 13
- Published applications
- 25
- Assignees
- 21
- Inventors
- 60
- Latest grant
- 13 Oct 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 5 |
| 2009 | 1 | 2 |
| 2010 | 2 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptor13 Oct 2020US 10,802,020 B2
- Diagnosis and prognosis for chronic fatigue syndrome17 Sep 2019US 10,416,174 B1Arizona Board of Regents on behalf of Arizona State University
- Methods and compositions for biomarkers of fatigue19 Apr 2016US 9,316,651 B2Hyperion Biotechnology
- Methods and compositions for biomarkers of fatigue3 Feb 2015US 8,945,854 B2Hyperion Biotechnology
- Method and device for diagnosing chronic fatigue syndrome (CFS) by using near infrared spectrum31 Jul 2012US 8,233,960 B2Fatigue Science Laboratory Inc.
- Biomarkers for chronic fatigue syndrome and long covid and uses thereof26 Feb 2026US 2026/0056211 A1Bristol-Myers Squibb Company
- Biosignatures for Fatigue Syndromes29 May 2025US 2025/0172571 A1Laboratorium M. Nuytinck
- Inflammatory cytokines and fatigue in subject with a complement mediated disease9 Nov 2023US 2023/0357433 A1Bioverativ USA Inc.
- Biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs)17 Nov 2022US 2022/0364170 A1National Center of Neurology and Psychiatry
- Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptor7 Jun 2018US 2018/0156793 A1Celltrend GmbH
Most cited
By later US patents
- Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA11US 5,776,690 A1998
- Ribonuclease L inhibitor as an indicator of chronic fatigue syndrome8US 5,766,859 AImmunosciences Lab, Inc. · 1998
- Diagnosis and prognosis for chronic fatigue syndrome6US 10,416,174 B1Arizona Board of Regents on behalf of Arizona State University · 2019
- Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response5US 6,692,969 B12004
- Methods for assessing fatigue level and applications thereof4US 7,824,888 B2Virus Ikagaku Kenkyusho Inc. · 2010